Induction of apoptosis in an androgen-independent mouse cell line by transforming growth factor-β1

Journal of Experimental Therapeutics and Oncology

Volumn 1, Issue 6, 1996, Pages 377-384

  Furuya, Yuzo ^a   Ohta, Sho ^a   Shimazaki, Jun ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Androgen independent; Apoptosis; Cell cycle; TGF 1

Indexed keywords

ANDROGEN; CALCIUM; DNA FRAGMENT; RNA; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; FLOW CYTOMETRY; ISOLATION AND PURIFICATION; METABOLISM; MOUSE; NORTHERN BLOTTING; PHYSIOLOGY;

ANDROGENS; ANIMALS; APOPTOSIS; BLOTTING, NORTHERN; CALCIUM; CELL SURVIVAL; DNA FRAGMENTATION; FLOW CYTOMETRY; MICE; RNA, NEOPLASM; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0030274689     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Catalona W J, Scott W W. Carcinoma of the prostate. J Urol 119: 1-8, 1978.
2. Schulze H, Isaacs JT, Senge T. Inability of complete androgen blockade to increase survival of patients with advanced prostate cancer as compared to standard hormonal therapy. J Urol 137: 909-911, 1987.
3. Moses HL, Yang EY, Pietenpol JA. TGF-β stimulation and inhibition of cell proliferation. New mechanistic insights. Cell 63: 245-247, 1990.
4. Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK. Transforming growth factor β. Potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res 48: 3898-3904, 1988.
5. Hoosein NM, Brattain DE, McKnight MK, Levine AE, Brattain MG. Characterization of the inhibitory effects of transforming growth factor-β on a human colon carcinoma cell line. Cancer Res 47: 2950-2954, 1987.
6. Lin JK, Chou CK. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor β1. Cancer Res 52: 385-388, 1992.
7. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF-β receptor. Nature 370: 341-347, 1994.
8. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A. p27KIP1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8: 9-22, 1994.
9. Rotello RJ, Lieberman RC, Purchio AF, Gerschenson LE. Coordinated regulation of apoptosis and cell proliferation by transforming growth factor β1 in cultured uterine epithelial cells. Proc Natl Acad Sci USA 88: 3412-3415, 1991.
10. Yanagihara K, Tsumuraya M. Transforming growth factor β1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res 52: 4042-4045, 1992.
11. Martikainen P, Kyprianou N, Isaacs JT. Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells. Endocrinology 127: 2963-2968, 1990.
12. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W, Schulte-Hermann R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc Natl Acad Sci USA 89: 5408-5412, 1992.
13. Ichikawa T, Akimoto S, Hayata I, Shimazaki, J. Progression and selection in heterogeneous tumor composed of androgen-responsive Shionogi Carcinoma 115 and its autonomous subline (Chiba Subline 2). Cancer Res 49: 367-371, 1989.
14. Furuya Y, Sato N, Akakura K, Ichikawa T, Suzuki N, Sato R, Shimazaki J. Paracrine growth stimulation of androgen-responsive Shionogi Carcinoma 115 by its autonomous subline (Chiba Subline). Cancer Res 50: 4979-4983, 1990.
15. Furuya Y, Shirasawa H, Sato N, Watabe Y, Simizu B, Shimazaki J. Loss of androgen dependency with preservation of functional androgen receptors in androgen-dependent mouse tumor (Shionogi Carcinoma 115). J Steroid Biochem Molec Biol 42: 569-574, 1992.
16. Furuya Y, Isaacs JT, Shimazaki J. Induction of programmed death/ apoptosis in androgen dependent mouse mammary tumor cell line (Shionogi carcinoma 115) by androgen withdrawal. Jpn J Cancer Res 86: 1159-1165, 1995.
17. Furuya Y, Isaacs JT. Proliferation-dependent vs. independent programmed cell death of prostatic cancer cells involves distinct gene regulation. Prostate 25: 301-309, 1994.
18. Ueda N, Shah SV. Endonuclease-induced DNA damage and cell death in oxidant injury to renal tubular epithelial cells. J Clin Invest 90: 2593-2597, 1992.
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
20. Furuya Y, Isaacs JT. Differential gene regulation during programmed death (apoptosis) versus proliferation of prostatic glandular cells induced by androgen manipulation. Endocrinology 133: 2660-2666, 1994.
21. Furuya Y, Lundmo P, Short AD, Gill DL, Isaacs JT. The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res 54: 6167-6175, 1994.
22. Vindelov LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323-327, 1983.
23. Furuya Y, Shimazaki J. Appptosis in androgen-independent mouse mammary tumor cells induced by 5-fluorodeoxyuridine but not by androgen withdrawal. Anticancer Res in press, 1996.
24. Buttyan R, Olsson CA, Pintar J, Chang C, Bandyk M, Ng P, Sawczuk IS. Induction of the TRPM-2 gene in cells undergoing programmed death. Mol Cell Biol 9: 3473-3481, 1989.
25. Kyprianou N, Isaacs JT. 'Thymineless' death in androgen-independent prostatic cancer cells. Biochem Biophys Res Commun 165: 73-81, 1989.
26. Kyprianou N, Isaacs JT. Identification of a cellular receptor for transforming growth factor-β in rat ventral prostate and its negative regulation by androgens. Endocrinology 123: 2124-2131, 1988.
27. Kyprianou N, Isaacs JT. Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 3: 1515-1522, 1989.
28. Isaacs JT, Furuya Y, Berges R. The role of androgen in the regulation of programmed cell death/apoptosis in normal and malignant prostatic tissue. Semin Cancer Biol 5: 391-400, 1994.
29. Martikainen P, Kyprianou N, Tucker RW, Isaacs JT. Programmed death of nonproliferating androgen independent prostatic cancer cells. Cancer Res 51: 4693-4700, 1991.
30. 2+-dependent endonuclease as an early event in castration-induced prostatic cell death. Prostate 13: 103-117, 1988.
31. Vandewalle B, Hornez L, Wattez N, Revillion F, Lefebvre J. Vitamin-D3 derivatives and breast-tumor cell growth. Effect on intracellular calcium and apoptosis. Int J Cancer 61: 806-811, 1995.
32. Furuya Y, Lin XS, Walsh JC, Nelson WG, Isaacs JT. Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction. Endocrinology 136: 1898-1906, 1995.